PYRAZOLOOE3,4-GAAQUINOLIN-, PYRIDOOE2,3-GAA-QUINAZOLIN-, THIAZOLOOE4,5-GAAQUINOLIN-, OXAZOLOOE4,5-GAAQUINOLIN- OG PYRROLOOE3,4-GAAQUINOLIN-DERIVATER SAMT FREMGANGSMAADE TIL FREMSTILLING HERAF

7- or 8-Substituted, partially hydrogenated pyrazolo[3,4-g]quinoline, thiazolo[4,5-g]quinoline, oxazolo[4,5-g]quinoline, and pyrrolo[3,4-g]quinoline derivatives, and 8- or 9-substituted, partially hydrogenated pyrido[2,3-g]quinazoline derivatives of formula: wherein: represents or are D-2 dopamine a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SCHAUS, JOHN MEHNERT, HUSER, DIANE LYNN
Format:	Patent
Sprache:	dan
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	SCHAUS, JOHN MEHNERT HUSER, DIANE LYNN
description	7- or 8-Substituted, partially hydrogenated pyrazolo[3,4-g]quinoline, thiazolo[4,5-g]quinoline, oxazolo[4,5-g]quinoline, and pyrrolo[3,4-g]quinoline derivatives, and 8- or 9-substituted, partially hydrogenated pyrido[2,3-g]quinazoline derivatives of formula: wherein: represents or are D-2 dopamine agonists. 6-Oxo-1-substituted-octahydroquinolines and 6-oxo-1-substituted-decahydroquinolines which are additionally substituted in the 3- or 4-position are intermediates useful in preparation of the dopamine agonists. Acetals of 4,6-dioxo-1-substituted-decahydroquinoline 3-carboxylic acid esters enable synthesis of the foregoing compounds.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK299787A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK299787A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK299787A3</originalsourceid><addsrcrecordid>eNrjZNgfEBnkGOXv4-_vaqxjouvu6BgY6unn7-Ppp6ujAJTzdAHKGOkYg2R0QVIgxWDJEA9PqEYTHVM0jf4ROKQU_N1BpgZhtdDFNcgzzDHENUgh2NE3RMEtyNXX3dHPPdjX0dHFVSHE0wcsFAxkAFW7K3i4Bjm68TCwpiXmFKfyQmluBjk31xBnD93Ugvz41OKCxOTUvNSSeBdvI0tLcwtzR2OCCgBfrEwh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRAZOLOOE3,4-GAAQUINOLIN-, PYRIDOOE2,3-GAA-QUINAZOLIN-, THIAZOLOOE4,5-GAAQUINOLIN-, OXAZOLOOE4,5-GAAQUINOLIN- OG PYRROLOOE3,4-GAAQUINOLIN-DERIVATER SAMT FREMGANGSMAADE TIL FREMSTILLING HERAF</title><source>esp@cenet</source><creator>SCHAUS, JOHN MEHNERT ; HUSER, DIANE LYNN</creator><creatorcontrib>SCHAUS, JOHN MEHNERT ; HUSER, DIANE LYNN</creatorcontrib><description>7- or 8-Substituted, partially hydrogenated pyrazolo[3,4-g]quinoline, thiazolo[4,5-g]quinoline, oxazolo[4,5-g]quinoline, and pyrrolo[3,4-g]quinoline derivatives, and 8- or 9-substituted, partially hydrogenated pyrido[2,3-g]quinazoline derivatives of formula: wherein: represents or are D-2 dopamine agonists. 6-Oxo-1-substituted-octahydroquinolines and 6-oxo-1-substituted-decahydroquinolines which are additionally substituted in the 3- or 4-position are intermediates useful in preparation of the dopamine agonists. Acetals of 4,6-dioxo-1-substituted-decahydroquinoline 3-carboxylic acid esters enable synthesis of the foregoing compounds.</description><edition>4</edition><language>dan</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1987</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19871217&DB=EPODOC&CC=DK&NR=299787A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19871217&DB=EPODOC&CC=DK&NR=299787A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SCHAUS, JOHN MEHNERT</creatorcontrib><creatorcontrib>HUSER, DIANE LYNN</creatorcontrib><title>PYRAZOLOOE3,4-GAAQUINOLIN-, PYRIDOOE2,3-GAA-QUINAZOLIN-, THIAZOLOOE4,5-GAAQUINOLIN-, OXAZOLOOE4,5-GAAQUINOLIN- OG PYRROLOOE3,4-GAAQUINOLIN-DERIVATER SAMT FREMGANGSMAADE TIL FREMSTILLING HERAF</title><description>7- or 8-Substituted, partially hydrogenated pyrazolo[3,4-g]quinoline, thiazolo[4,5-g]quinoline, oxazolo[4,5-g]quinoline, and pyrrolo[3,4-g]quinoline derivatives, and 8- or 9-substituted, partially hydrogenated pyrido[2,3-g]quinazoline derivatives of formula: wherein: represents or are D-2 dopamine agonists. 6-Oxo-1-substituted-octahydroquinolines and 6-oxo-1-substituted-decahydroquinolines which are additionally substituted in the 3- or 4-position are intermediates useful in preparation of the dopamine agonists. Acetals of 4,6-dioxo-1-substituted-decahydroquinoline 3-carboxylic acid esters enable synthesis of the foregoing compounds.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1987</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNgfEBnkGOXv4-_vaqxjouvu6BgY6unn7-Ppp6ujAJTzdAHKGOkYg2R0QVIgxWDJEA9PqEYTHVM0jf4ROKQU_N1BpgZhtdDFNcgzzDHENUgh2NE3RMEtyNXX3dHPPdjX0dHFVSHE0wcsFAxkAFW7K3i4Bjm68TCwpiXmFKfyQmluBjk31xBnD93Ugvz41OKCxOTUvNSSeBdvI0tLcwtzR2OCCgBfrEwh</recordid><startdate>19871217</startdate><enddate>19871217</enddate><creator>SCHAUS, JOHN MEHNERT</creator><creator>HUSER, DIANE LYNN</creator><scope>EVB</scope></search><sort><creationdate>19871217</creationdate><title>PYRAZOLOOE3,4-GAAQUINOLIN-, PYRIDOOE2,3-GAA-QUINAZOLIN-, THIAZOLOOE4,5-GAAQUINOLIN-, OXAZOLOOE4,5-GAAQUINOLIN- OG PYRROLOOE3,4-GAAQUINOLIN-DERIVATER SAMT FREMGANGSMAADE TIL FREMSTILLING HERAF</title><author>SCHAUS, JOHN MEHNERT ; HUSER, DIANE LYNN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK299787A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>1987</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SCHAUS, JOHN MEHNERT</creatorcontrib><creatorcontrib>HUSER, DIANE LYNN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SCHAUS, JOHN MEHNERT</au><au>HUSER, DIANE LYNN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRAZOLOOE3,4-GAAQUINOLIN-, PYRIDOOE2,3-GAA-QUINAZOLIN-, THIAZOLOOE4,5-GAAQUINOLIN-, OXAZOLOOE4,5-GAAQUINOLIN- OG PYRROLOOE3,4-GAAQUINOLIN-DERIVATER SAMT FREMGANGSMAADE TIL FREMSTILLING HERAF</title><date>1987-12-17</date><risdate>1987</risdate><abstract>7- or 8-Substituted, partially hydrogenated pyrazolo[3,4-g]quinoline, thiazolo[4,5-g]quinoline, oxazolo[4,5-g]quinoline, and pyrrolo[3,4-g]quinoline derivatives, and 8- or 9-substituted, partially hydrogenated pyrido[2,3-g]quinazoline derivatives of formula: wherein: represents or are D-2 dopamine agonists. 6-Oxo-1-substituted-octahydroquinolines and 6-oxo-1-substituted-decahydroquinolines which are additionally substituted in the 3- or 4-position are intermediates useful in preparation of the dopamine agonists. Acetals of 4,6-dioxo-1-substituted-decahydroquinoline 3-carboxylic acid esters enable synthesis of the foregoing compounds.</abstract><edition>4</edition><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	dan
recordid	cdi_epo_espacenet_DK299787A
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	PYRAZOLOOE3,4-GAAQUINOLIN-, PYRIDOOE2,3-GAA-QUINAZOLIN-, THIAZOLOOE4,5-GAAQUINOLIN-, OXAZOLOOE4,5-GAAQUINOLIN- OG PYRROLOOE3,4-GAAQUINOLIN-DERIVATER SAMT FREMGANGSMAADE TIL FREMSTILLING HERAF
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T05%3A42%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SCHAUS,%20JOHN%20MEHNERT&rft.date=1987-12-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK299787A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true